Table 3

Adverse events and postoperative outcomes

VariablesLow
(n=7940)
Intermediate
(n=20 075)
High
(n=5825)
P value
Adverse events (%)
Vasospasm13.037.955.3<0.001
Hydrocephalus34.160.569.4<0.001
Urinary tract infection1.316.446.5<0.001
Post-procedural fever0.50.20.50.108
Pressure ulcer0.01.44.0<0.001
Sepsis0.46.613.8<0.001
Cardiogenic shock0.31.41.50.002
Cerebral infarction2.211.522.4<0.001
Syndrome of inappropriate antidiuretic hormone secretion3.54.24.10.421
Hypo-osmolar hyponatremia15.930.533.4<0.001
Pulmonary embolism0.41.82.6<0.001
Phlebitis0.30.81.10.045
Acute deep vein thrombosis2.07.813.6<0.001
Periprocedural stroke0.41.61.70.001
Acute myocardial infarction1.33.23.8<0.001
Acute respiratory failure14.247.366.4<0.001
Acute kidney injury1.510.217.9<0.001
Mechanical ventilation16.247.566.1<0.001
Tracheostomy2.111.422.3<0.001
Gastrostomy3.014.131.0<0.001
Any adverse event59.992.499.2<0.001
Number of adverse events<0.001
048.714.43.3
127.518.09.2
>123.867.687.6
Mortality (%)6.415.310.8<0.001
Length of stay (days)
Mean±SD11.7±8.218.7±14.126.6±20.1<0.001
Median (IQR)11 (7–15)16 (11–23)22 (16–31)<0.001
Total cost of admission ($)
Mean±SD62 888±37 75799 670±63 446134 937±80 331<0.001
Median (IQR)55 247 (39 050–75 934)83 358 (56 981–122 835)112 881 (82 426–164 897)<0.001
Disposition (%)<0.001
Routine75.139.819.6
Non-routine17.344.469.4
Other7.615.711.1